Eledon Pharmaceuticals is poised to revolutionize kidney transplant care with tegoprubart, targeting a $6B market. Read why ...

Only two calcineurin inhibitors exist, cyclosporine and tacrolimus ... Using the International Society for Heart and Lung Transplantation Thoracic Organ Transplant Registry data, a research ...

Only two calcineurin inhibitors exist, cyclosporine and tacrolimus ... Using the International Society for Heart and Lung Transplantation Thoracic Organ Transplant Registry data, a research ...

Only two calcineurin inhibitors exist, cyclosporine and tacrolimus ... Using the International Society for Heart and Lung Transplantation Thoracic Organ Transplant Registry data, a research ...

Preventing this complication for those who receive a lung transplant is of the highest priority, as there are no universally effective treatments for CLAD once it is established. The most common of ...

Only two calcineurin inhibitors exist, cyclosporine and tacrolimus ... Using the International Society for Heart and Lung Transplantation Thoracic Organ Transplant Registry data, a research team led ...

There has been little innovation in immunosuppression therapy for organ transplant patients over ... and mortality was very high until 1983 when cyclosporine, a calcineurin inhibitor (CNI ...

Only two calcineurin inhibitors exist, cyclosporine and tacrolimus ... Using the International Society for Heart and Lung Transplantation Thoracic Organ Transplant Registry data, a research team led ...

Cyclosporine dramatically changed the science ... of mainstay transplant immunosuppression for nearly 40 years. Solid organ transplantation in humans has a relatively short history, spanning ...

Less than a month after Kadmon Pharma launched its first product – Rezurock for a complication of organ transplants ... that can follow a bone marrow transplant and which occurs when the ...